UK Biobank launches its Access Procedures today (Wednesday 14th), which govern the way the resource can be used by scientists to improve the health of future generations.
14 December, 2011
A new pooled analysis presented today at the International Diabetes Federation (IDF) 21st World Diabetes Congress has demonstrated that people with type 2 diabetes taking 'Januvia' (sitagliptin) experienced a lower incidence of major cardiovascular (CV) events (MACE) compared to those treated with a sulphonylurea (SU).
06 December, 2011